BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28276102)

  • 1. Mucormycosis at a tertiary care centre in Gujarat, India.
    Patel AK; Patel KK; Patel K; Gohel S; Chakrabarti A
    Mycoses; 2017 Jun; 60(6):407-411. PubMed ID: 28276102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
    Bala K; Chander J; Handa U; Punia RS; Attri AK
    Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases.
    Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Araiza J; Kassack JJ; Del Angel-Arenas T; Moisés-Hernández JF; Paredes-Farrera F; Gómez-Apo E; Treviño-Rangel RJ; González GM
    Mycoses; 2021 Apr; 64(4):372-380. PubMed ID: 33253454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucormycosis in hematologic patients.
    Pagano L; Offidani M; Fianchi L; Nosari A; Candoni A; Picardi M; Corvatta L; D'Antonio D; Girmenia C; Martino P; Del Favero A;
    Haematologica; 2004 Feb; 89(2):207-14. PubMed ID: 15003897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
    Lanternier F; Dannaoui E; Morizot G; Elie C; Garcia-Hermoso D; Huerre M; Bitar D; Dromer F; Lortholary O;
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S35-43. PubMed ID: 22247443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases.
    Samaddar A; Shrimali T; Sharma A
    Mycoses; 2023 Mar; 66(3):181-195. PubMed ID: 36227645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
    Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
    Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive mucormycosis in a tertiary care hospital in the western region of Saudi Arabia: 11-year retrospective chart review from 2009 to 2019.
    Almarhabi H; Al-Asmari E; Munshi A; Farahat F; Al-Amri A; Almaghraby HQ; Alharbi M; Althaqafi A
    J Infect Public Health; 2022 Dec; 15(12):1466-1471. PubMed ID: 36403403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
    Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A
    Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucormycosis in hospitalized patients at a tertiary care center in Lebanon: a case series.
    El Zein S; El-Cheikh J; El Zakhem A; Ibrahim D; Bazarbachi A; Kanj SS
    Infection; 2018 Dec; 46(6):811-821. PubMed ID: 30121719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
    Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
    Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.
    Patel A; Kaur H; Xess I; Michael JS; Savio J; Rudramurthy S; Singh R; Shastri P; Umabala P; Sardana R; Kindo A; Capoor MR; Mohan S; Muthu V; Agarwal R; Chakrabarti A
    Clin Microbiol Infect; 2020 Jul; 26(7):944.e9-944.e15. PubMed ID: 31811914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhino-orbito-cerebral mucormycosis: five cases.
    Toumi A; Larbi Ammari F; Loussaief C; Hadhri R; Ben Brahim H; Harrathi K; Ben Romdhane F; Koubaa J; Chakroun M
    Med Mal Infect; 2012 Dec; 42(12):591-8. PubMed ID: 23116703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.
    Heimann SM; Vehreschild MJGT; Cornely OA; Heinz WJ; Grüner B; Silling G; Kessel J; Seidel D; Vehreschild JJ
    J Hosp Infect; 2019 Mar; 101(3):339-346. PubMed ID: 30423409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
    Chowdhary A; Kathuria S; Singh PK; Sharma B; Dolatabadi S; Hagen F; Meis JF
    Mycoses; 2014 Dec; 57 Suppl 3():97-107. PubMed ID: 25250768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucormycosis: An 8-year experience of a tertiary care centre in Saudi Arabia.
    Elzein F; Albarrag A; Kalam K; Arafah M; Al-Baadani A; Eltayeb N; Aloteibi F; Alrashed A; Abdullah RA; Alasiri S
    J Infect Public Health; 2020 Nov; 13(11):1774-1779. PubMed ID: 32891591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhizopus homothallicus rhino-orbital-cerebral mucormycosis: Six cases from a tertiary care Centre, North India.
    Gupta MK; Selvaraj S; Tilak R; Kumar N; Kumar R; Chakravarty J
    Trop Med Int Health; 2023 Feb; 28(2):144-150. PubMed ID: 36517958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].
    Yang YM; Fang BM; Xu XM; Fang F; Pan MM; Zhong XF; Sun TY
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):572-6. PubMed ID: 24252732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.